Last updated on May 2017

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)


Brief description of study

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)

Detailed Study Description

Alchemist includes several clinical trials. Their goal is to test new therapies for patients like you: those with early stage non-small cell lung cancer whose tumor can be surgically removed. Some of the ALCHEMIST trials are seeking patients with specific mutations, or changes, in their cancer tumors. These changes are relatively rare: they exist in about 10 percent or less of all tumors. If your tumor has these changes, you may be given a new type of medicine called “targeted therapy.” These medicines are developed to “target,” or attack the changes in your tumor and prevent the cancer from returning. If your tumor does not have a specific mutation or change to the gene, you may have an opportunity to enroll in another ALCHEMIST study and receive an “immunotherapy” medicine that may help your own immune system prevent the cancer from returning.

Clinical Study Identifier: TX149717

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.